Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Hee Won Yoo"'
Autor:
Hee-Won Yoo, Sin-Sil Han
Publikováno v:
Journal of Critical Social Welfare. 77:103-134
Publikováno v:
Journal of Critical Social Welfare. 76:23-58
Publikováno v:
Journal of Critical Social Welfare. 75:7-31
Autor:
Hee-Won Yoo, Sin-Sil Han
Publikováno v:
Journal of Critical Social Welfare. 74:109-148
Autor:
Yong Beom Cho, Woo Yong Lee, Kyu Joo Park, Mihyung Kim, Hee-Won Yoo, Chang Sik Yu M.D., Ph.D.
Publikováno v:
Cell Transplantation, Vol 22 (2013)
The present study was designed to evaluate the safety and potential of adipose tissue-derived stem cells (ASCs) for the treatment of Crohn's fistula. In this dose escalation study, patients were sequentially enrolled into three dosing groups with at
Externí odkaz:
https://doaj.org/article/ca6ef5d1e1df49daaeb6691d09a5ed54
Autor:
Do Sun Kim, Hunjoo Ha, Mihyung Kim, Inok Kim, Kee Ho Song, Sang Nam Yoon, Woo Yong Lee, Chang Sik Yu, Kyu Joo Park, Yong Beom Cho, Hee Won Yoo, Sang Hun Jung
Publikováno v:
Stem Cells. 31:2575-2581
Fistula is a representative devastating complication in Crohn's patients due to refractory to conventional therapy and high recurrence. In our phase I clinical trial, adipose tissue-derived stem cells (ASCs) demonstrated their safety and therapeutic
Publikováno v:
Cell Transplantation, Vol 22 (2013)
The present study was designed to evaluate the safety and potential of adipose tissue-derived stem cells (ASCs) for the treatment of Crohn's fistula. In this dose escalation study, patients were sequentially enrolled into three dosing groups with at
Autor:
Young Suk Lee, Tae-Hun Kim, Haak Cheoul Kim, Joon Yeol Han, Myung Seok Lee, Byung Chul Yoo, Mong Cho, Young Soo Kim, Seong Gyu Hwang, Soon Ho Um, Byung Hoon Han, Cheol Ju Han, Young Hwa Chung, Heon Ju Lee, Se Hyun Cho, Kwon Yoo, Kwan Soo Byun, Hyo Suk Lee, Seung Woon Paik, Kwang Cheol Koh, Ju Hyun Kim, Chae Yoon Chon, Jin Mo Yang, Hee Won Yoo, Soo Hyung Ryu, Byung Ik Kim, Jae Seok Hwang, Kwan Sik Lee
Publikováno v:
Journal of Gastroenterology. 46:410-414
This study was conducted to evaluate the durability of clevudine-induced viral response after the withdrawal of treatment. Patients who showed a complete response [alanine aminotransferase (ALT) normalization and hepatitis B virus (HBV) DNA
Autor:
Joon-Yeol Han, Mong Cho, Kwan Soo Byun, J.M. Yang, Young Soo Kim, Tae-Hun Kim, Kwon Yoo, Soon-Ho Um, Hee-Won Yoo, Young Suk Lee, Byung Hoon Han, Hyo-Suk Lee, Young-Oh Kweon, Byungik Kim, Jae Seok Hwang, Heon Young Lee, Dae-Ghon Kim, Yun Soo Kim, Seung Woon Paik, Seong Gyu Hwang, Young-Hwa Chung, Sung-Kyu Choi, Kwan Sik Lee, S. G. Cho, Byung Chul Yoo, Jong-Young Choi, M. Lee, Joong-Won Park, Soo Hyung Ryu, Ju Hyun Kim, Sook-Hyang Jeong, Haak Cheoul Kim, Youn-Jae Lee, Chae Yoon Chon, Heon Ju Lee
Publikováno v:
Hepatology. 45:1172-1178
Clevudine is a pyrimidine analogue with potent and sustained antiviral activity against HBV. The present study evaluated the safety and efficacy of 30 mg clevudine once daily for 24 weeks and assessed the durable antiviral response for 24 weeks after
Publikováno v:
Bioorganic & Medicinal Chemistry. 8:2079-2083
2-Methyl-1-substituted-imidazo[4,5- g ]quinoline-4,9-diones and 7,8-dihydro-10 H -[1,4]oxazino -[3′,4′:2,3]imidazo[4,5- g ]quinoline-5,12-dione ( 19 ) derivatives have been synthesized from 6,7-dichloro-5,8-quinolinedione for developing the new a